A highly potent inhibitor of calmodulin-sensitive phosphodiesterase (PDE) activity was isolated from the culture broth of an unidentified fungal isolate, SCF-125. A chemically defined medium was developed for production of this compound. The PDEinhibitor was isolated from the fermentation filtrate by adsorption on a macro-reticular resin and further purified by gel filtration chromatography and reverse-phase HPLC. The major PDE inhibitor was identified as cephalochromin, a bis-naphthopyrone, by spectral data analysis. The compound, SCH45752, inhibited calmodulinsensitive PDE activities with IC50 values of 40~47nM. It inhibited the activities of calmodulin-independent PDE and various protein kinases with higher IC50 values (2~40jUM). SCH45752 does not appear to be a calmodulin antagonist. Furthermore, SCH45752 affects smooth muscle contraction at a concentration of 30 /*m; it potentiated the relaxing effect of sodium nitroprusside on carotid artery media contracted by histamine. Thus SCH45752 is one of the most potent inhibitors of calmodulin-sensitive PDEactivity known, and it is capable of exerting a pharmacological effect in at least one intact tissue model.
A highly potent inhibitor of calmodulin-sensitive phosphodiesterase (PDE) activity was isolated from the culture broth of an unidentified fungal isolate, SCF-125. A chemically defined medium was developed for production of this compound. The PDEinhibitor was isolated from the fermentation filtrate by adsorption on a macro-reticular resin and further purified by gel filtration chromatography and reverse-phase HPLC. The major PDE inhibitor was identified as cephalochromin, a bis-naphthopyrone, by spectral data analysis. The compound, SCH45752, inhibited calmodulinsensitive PDE activities with IC50 values of 40~47nM. It inhibited the activities of calmodulin-independent PDE and various protein kinases with higher IC50 values (2~40jUM). SCH45752 does not appear to be a calmodulin antagonist. Furthermore, SCH45752 affects smooth muscle contraction at a concentration of 30 /*m; it potentiated the relaxing effect of sodium nitroprusside on carotid artery media contracted by histamine. Thus SCH45752 is one of the most potent inhibitors of calmodulin-sensitive PDEactivity known, and it is capable of exerting a pharmacological effect in at least one intact tissue model. Cyclic nucleotides have long been knownto play important roles as second messengers regulating manycell functions. Cyclic nucleotide phosphodiesterases (PDE), which influence intracellular cyclic AMP and cyclic GMPconcentrations by regulating the rate of cyclic nucleotide breakdown, exist in multiple isozymic forms, which differ not only in their biochemical properties but also in their tissue distributions.
The ability to selectively inhibit particular PDE isozymes carries the promise of tissue-specific pharmacological effects. In the course of our screening program to obtain a novel calmodulin-sensitive PDEinhibitor, we have isolated a bis-naphthopyrone, SCH 45752 (1) from a fungal culture (SCF-125). SCH 45752 was isolated and purified. Based on the spectral data, the structure of SCH 45752 appears to be the same as cephalochromin (Fig. 1 ). In this paper we describe the fermentation, isolation, structure and the physico-chemical and pharmacological properties of SCH45752.
Materials and Methods Fermentation Stock cultures were maintained as frozen whole broths at -20°C in a final concentration of 10% glycerol. A 250-ml Erlenmeyer flask containing 70 ml of seed medium was inoculated with 3.0 ml of stock culture. The flask was incubated at 24°C on a rotary shaker at 300rpm for 48 hours. The seed medium consisted of proteus peptone 0.5%, sodium chloride 0.5%, potassium dihydrogen phosphate 0.5%, Difco yeast extract 0.3%, Cerelose 0.2%, soybean grits 0.5%, and Dow-Corning antifoam B 0.2ml per liter of tap water. Twenty-five ml of this seed culture was used to inoculate a 2-liter Erlenmeyer flask containing 500 ml of the same germination mediumand incubated as above. This second stage germination inoculum (17.5 ml) was used to inoculate a 2-liter Erlenmeyer flask containing 350ml of fermentation production medium consisting of Neopeptone 1.0% and Cerelose 4%. The pH was adjusted to 7.0+0.2 prior to autoclaving. The fermentation was carried out at 24°C on a rotary shaker at 300 rpm. 500ml of this third stage inoculum was used to inoculate 1 0-liter fermentors using the same conditions as before. The production of active compound was monitored by PDEinhibition. A typical time-course study of fermentation in a 10-liter tank is shown in Fig. 2 . The optimum PDEinhibitory activity was achieved at 90~96 hours before depletion.
Isolation
The steps leading to isolation and purification of the PDEinhibitor are outlined in Fig. 3 . After fermentation (4 liters), the culture broth was filtered to remove cells. The active compound from the filtrate was adsorbed onto Amberlite XAD-16resin and the inactive spent filtrate was decanted off. The charged resin was eluted with 75%methanol -water. Purification of the PDEinhibitor was achieved by gel filtration on a Sephadex LH-20 column in methanol and purification on a reverse-phase C-18 silica column (1.9 x 30cm) eluting with a mixture of methanol and 0.01 n NaH2PO4 (pH 3.0 with phosphoric acid, 65 : 35). Methanol was removed from the active peak eluate, and the activity was separated from the aqueous solution by ethyl acetate extraction. Twoactive components were separated by preparative HPLC using a reverse-phase phenyl column (1.9 x 30cm) and elution with 0.01 n NaH2PO4 (adjusted to pH 3.0 The components from the active peak eluates were obtained as above to yield 95mg of SCH 45752 (1) and 1.2mg of a dehydro derivative (2) . The analytical HPLCprofile of the mixture of two compounds (enriched with 2) are shown in Phosphodiesterase Assays Calmodulin-sensitive PDE was purchased from Boehringer-Mannheim Biochemicals (CalmodulinDeflcient Phosphodiesterase from Beef Heart, Cat. No. 108 235). Calmodulin-sensitive (Peak I) and calmodulin-independent (Peak III) PDEs, prepared from rabbit aortic media, were provided by Dr. Ho SamAhn, Schering-Plough Research Institute. Other materials and measurement of hydrolysis of either 1 /xm cyclic AMPor 1 /xm cyclic GMPwere as described by Ahn et al.M yosin Light Chain Kinase Assays Bovine aortic smooth muscle myosin light chain kinase (MLCK)was provided by Dr. M. Cable, Schering-Plough Research Institute. MLCK activity was measured in a 100-ml reaction mixture containing 50 mM3-(iV-morpholino)-propanesulfonic acid, 100 mMcalcium acetate, 10 mMmagnesium acetate, 100 nM calmodulin (Sigma), 30 mMMLCKsubstrate (Lys-Lys-Arg-Pro-Gln-Arg-Ala-Thr-Ser-Asn-Val-Phe-Ser-NH2; Peninsula Laboratories, Cat. No. 8654), 25 mM[32P]ATP (3 x 104 Bq/nmol; New England Nuclear), SCH45752 at various concentrations, and sufficient MLCK to catalyze approximately 10%maximal phosphorylation of the substrate in 30 minutes at 25°C, pH 7.0. The reaction was terminated with the addition of 100ml of 150him H3PO4.Aliquots of the reaction mixture were spotted on WhatmanP-81 phosphocellulose paper squares, which were then processed for counting as described elsewhere.2) Cyclic AMP-dependent Protein Kinase Assays Bovine heart cyclic AMP-dependent protein kinase catalytic subunit was supplied by Dr. Jackie Corbin, Vanderbilt University. Phosphorylation of the substrate Leu-Arg-Arg-Ala-Ser-Leu-Gly (Peninsula Cat. No. 8650) was measured in a 250-//1 reaction mixture containing 5mMTris, 5mMTris-HCl, l mM magnesium acetate, 60mg/ml BSA, 16mMpeptide substrate, 16mM[32P]ATP, SCH 45752 at various concentrations, and sufficient kinase to catalyze approximately 1 0%maximal phosphorylation of substrate in 10 minutes at 25°C, pH 7.4. The reaction was terminated with H3PO4,and the product was quantitated as described elsewhere.2) Cyclic GMP-dependent Protein Kinase Assays Beef heart cyclic GMP-dependentprotein kinase was supplied by Dr. Corbin. Phosphorylation of the substrate Arg-Lys-Arg-Ser-Arg-Ala-Glu (Peninsula Cat. No. 8659) was measured in a 250-jul reaction mixture containing 5 mMTris, 5 mMTris-HCl, 1 him magnesium actate, 60mg/ml BSA, 2mMcyclic GMP, 29 mMpeptide substrate, 25 mM[32P]ATP, SCH45752 at various concentrations, and sufficient kinase to catalyze approximately 10%maximal phosphorylation of kemptamide in 10 minutes at 25°C, pH 7.4. The reaction was terminated with H3PO4, and the product was quantitated as described elsewhere.2) Protein Kinase C Assays Rat brain protein kinase C was partially purified (through the DEAE-Sephacel step) and its activity was assayed as described previously.3)
Contracting Smooth Muscle Preparation from Rabbit Aorta
Circumferential strips of porcine carotid artery media, approximately 2 x 10mm, were mounted and equilibrated for contraction measurements according to the procedure of Katsuki and Murad.4) The muscle strips were contracted to steady-state force levels with 1 mMhistamine, then relaxed by addition of sodium nitroprusside in increasing concentration, 1 nMto 1 mM,added cumulatively. Dose-response curves for sodium nitroprusside were measured in the absence and in the presence of 30/iM SCH45752.
Results and Discussion
The physico-chemical properties of SCH 45752 are summarized in Table 1 . SCH 45752 was isolated as a yellow solid, MP>300°C, and it showed an optical rotation [a]2/-5 + 541.1°. The IR and UVspectrum of SCH45752 are shown in Figs. 5 and 6, respectively. The IR spectrum showed the presence of hydroxyl groups (3400cm" 1) and ketonic function (1640cm" 1). The UV spectrum of this compound showed five absorption maxima, at 227, 275, 293, 327, and 420, which are characteristic of a naphthopyrone class of compounds, similar to that of ustilaginoidins. The FABmass spectrum showed the molecular weight to be 518 and the high-resolution mass measurements revealed the molecular formula to be C28H22O10. However, the 13C NMRspectrum showed only 14 carbon signals indicating a symmetrical bis-naphthopyrone. *H NMRexhibited proton signals at 3 1.4 (6H, due to 3-CH3's), 3 2.7 (4H due to two 3-CH2's), 3 4.5 (2H, due to 2-CH's), 3 5 .92 (2H, 10-CH's), 3 6 .55 (2H, 7-CH's), and two phenolic and two hydroxyl protons at 3 5.7 (2H), 3 9.7 (1H) and 3 10.1 (1H), respectively. From analysis of the *H NMRsignals and the other spectral data, we deduced structure 1 for SCH 45752 (Fig. 1) . From the spectral data, the structure of SCH45752 appears to be the same as cephalochromin.5'6) However, we could not obtain that it contains a double bond at the 2,3 position of one of the pyrone rings as shown in structure 2 ( Fig. 1) , the same as dihydroiso-ustilaginoidin A. SCH 45752 was a highly potent inhibitor of calmodulin-sensitive PDE activities from either bovine heart or bovine aorta (Table 2) . To evaluate the selectivity of SCH45752, we compared the potencies of SCH 45752 for inhibiting calmodulin-sensitive PDEs with the potencies for inhibiting another PDE isozyme as well as some other enzymes that utilize purine-containing substrates.
For the calmodulin-independent enzyme, Peak III PDE, cyclic AMPwas used as substrate because that enzyme is specific for the hydrolysis of cyclic AMP.As judged by IC50 values (Table 2) , SCH 45752 was far more potent as an inhibitor of calmodulin-sensitive PDEsthan as an inhibitor of calmodulin-independent (Peak III) PDEor of the four protein kinases tested. The concentration-effect curve for inhibition of calmodulin-sensitive PDE activity by SCH45752 (Fig.  7) suggests that SCH45752 is not specifically a calmodulin antagonist. Hydrolysis of 1 mMcyclic GMP by that enzyme was stimulated 6-fold by calcium-calmodulin. SCH45752 inhibited the PDE activities measured in the presence and in the absence of calciumà" calmodulin with indentical IC50 values (33 nMfor the experiment shown in Fig.7 ). Such would not be the case of a specific calmodulin antagonist, which would inhibit only activity stimulated by calmodulin. The ability of SCH45752 to inhibit cyclic nucleotide PDEssuggests the possibility of influencing smooth muscle contraction through manipulation of intracellular cyclic nucleotide concentrations. Lorenz and Wells have reported that the abilities of xanthines to potentiate the relaxant effects of sodium nitroprusside on vascular smooth muscle are predicted by their abilities to inhibit calmodulin-sensitive PDE.7) Consistent with those findings, SCH 45752 shifted to the left the concentration-effect curve for relaxation of bovine carotid artery smooth muscle by sodium nitroprusside (Fig. 8) . Thus SCH45752 may permeate smooth muscle cells and influence their contraction by inhibiting cyclic nucleotide hydrolysis that proceeds via calmodulin-sensitive PDEactivity.
Conclusions SCH45752 (cephalochromin), isolated from the culture broth of a fungal isolate, is a highly potent (nM range) inhibitor of at least some PDEsthat are regulated by calmodulin. The potencies of SCH45752 to inhibit the other enzymes tested, including another PDEisoenzyme and various protein kinases, are 
